Full Press Release Details
IDEAYA Announces Further Gilead Sciences Clinical Study Collaboration Evaluating Combination of Trodelvy R and IDE397 in MTAP Deletion NSCLC.
IDYA
IDEAYA Announces Further Gilead Sciences Clinical Study Collaboration Evaluating Combination of Trodelvy R and IDE397 in MTAP Deletion NSCLC
Key Takeaway: IDEAYA Announces Further Gilead Sciences Clinical Study Collaboration Evaluating Combination of Trodelvy R and IDE397 in MTAP Deletion NSCLC